Skip to content
KB
Company

Updated:

KERYX BIOPHARMACEUTICALS INC

KERYX BIOPHARMACEUTICALS INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001114220, and its reported...

Overview

KERYX BIOPHARMACEUTICALS INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001114220, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2018-02-21, it reported annual revenue of USD 60,641,000; net income of USD -163,440,000; total assets of USD 158,872,000 for the fiscal period ended 2017-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

Company overview

Legal name
KERYX BIOPHARMACEUTICALS INC
Former names in filing history
KERYX BIOPHAMAEUTICALS INC (2000-05-19 to 2000-06-30)
Classification
Company
Industry (SIC)
2834 — Pharmaceutical Preparations
Headquarters
Boston, MA, United States
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
0001114220

Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

Fiscal yearPeriod endRevenueNet incomeTotal assetsCash and equivalents
FY2017USD$60.6M-$163.4M$158.9M$93.5M
FY2016USD$32.0M-$161.1M$141.4M$111.8M
FY2015USD$13.7M-$123.1M$258.7M$200.3M
FY2014USD—-$111.5M$103.6M$74.3M

Recent SEC filings

FormFiledPeriodFiling
8-K8-K
10-Q10-Q
8-KFORM 8-K
8-KFORM 8-K
8-K8-K
10-Q10-Q
8-K8-K
8-K8-K
8-KFORM 8-K
8-K8-K
8-KFORM 8-K
DEF 14ADEF 14A

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Research KERYX BIOPHARMACEUTICALS INC in Altss

Track this company’s investors, transactions and relationships in Altss.

Book a demo

More Company profiles

KERYX BIOPHARMACEUTICALS INC | Boston Company | Altss